Immatics and UTHealth to collaborate on cellular manufacturing for Phase 1 clinical trials


October 19, 2015

Newswise — HOUSTON – (Oct. 16, 2015) – Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston (UTHealth) will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials. Read more